1. Industries
  2. Biotechnology companies

Biotechnology Companies & Verified Decision-Maker Emails

Biotechnology companies research and develop pharmaceuticals, diagnostics, genetic engineering, and life sciences innovations. Procurement cycles often involve research directors, lab executives, and founders.

Connect with biotech organizations scaling clinical research, product commercialization, and scientific innovation.

Identify and research relevant companies and decision-makers in the Biotechnology sector. Access verified business emails and direct contact details to support targeted lead generation, outreach campaigns, and higher conversion rates. Filter prospects by location, category, company size, and operating status to build precise, high-quality lists.

🔥 Why Use Our Directory?

Built for Real B2B Growth

Trusted by SDRs, agencies & founders who need verified, export-ready data.

📧

95%+ Email Verification Rate

Highly accurate contact data to minimize bounce rates and safeguard sender reputation.

🔄

Weekly Database Updates

Fresh company and contact records updated continuously.

🎯

Advanced Filtering

Filter by industry, country, company size & funding stage.

📊

Export-Ready CSV

Download clean, structured CSV files ready for your CRM or outreach tool.

Explore Plans

Companies

Found 391 firms

Prospects

Found 832 prospects · 136 Decision-Makers

Search Results

Showing 1–20 of 391 verified Biotechnology companies — browse profiles, find decision-makers, and export contacts.

Gilead Sciences

gilead.com

HQ: Foster City, California, United States

HQ: Foster City, California, United States

Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Manufacturing & Industrial

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 28, 2024
Founded Date: Jun 22, 1987
Number of Exits: 16
Company Type: For Profit
Stock Symbol: BIT:GILD
Operating Status: Active

  • Ahmed Afifi

    Vice President - Region Head Latin America

    a*********i@gilead.com

  • Kelsey Reedy

    Talent Advisor

    k**********y@gilead.com

  • Unclassified inbox

    public_affairs@gilead.com

  • Unclassified inbox

    bernard.murray@gilead.com

Show more 28 emails
View Gilead Sciences Profile Verify Gilead Sciences Emails Export Gilead Sciences Prospects

Seagen

seagen.com

HQ: Bothell, Washington, United States

HQ: Bothell, Washington, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals, Hospitals & Clinics

Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 12, 2024
Founded Date: 1998
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:SGEN
Operating Status: Active

  • Guy Padbury

    Senior Vice President, Translational Sciences

    g******y@seagen.com

  • Bryce Mansfield

    Executive Director, R&D Quality

    b********d@seagen.com

  • General Inquiries

    contact@seagen.com

  • Unclassified inbox

    pcarter@seagen.com

Show more 16 emails
View Seagen Profile Verify Seagen Emails Export Seagen Prospects

Tempus

tempus.com

HQ: Chicago, IL

HQ: Chicago, IL

Specialized In: AI & Machine Learning, Biotechnology, Healthcare & Medical

Business Type: Private
Employees: 501-1000
Rounds: Debt Financing
Last Investment Activity: Mar 27, 2024
Founded Date: 2015
Number of Exits: 1
Company Type: For Profit
Operating Status: Active

  • Ryan Fukushima

    Chief Operating Officer

    r**n@tempus.com

    ************0

  • Martin Stumpe

    Chief of AI

    m***********e@tempus.com

    ***********9

  • Admin Team

    admin@tempus.com

  • Customer Service

    support@tempus.com

Show more 16 emails
View Tempus Profile Verify Tempus Emails Export Tempus Prospects

Fresenius Medical Care

freseniusmedicalcare.com

HQ: Bad Homburg, Hessen, Germany

HQ: Bad Homburg, Hessen, Germany

Specialized In: Biotechnology, Healthcare & Medical, Medical Devices

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Dec 8, 2023
Founded Date: 1912
Number of Exits: 4
Company Type: For Profit
Stock Symbol: FRA:FME
Operating Status: Active

  • Tanya Coleman

    Certified Dialysis Technician

    t***********n@freseniusmedicalcare.com

  • Scott Sayres

    s**********s@freseniusmedicalcare.com

  • Unclassified inbox

    marketing.international@fmc-ag.com

  • Unclassified inbox

    orhan.tore@freseniusmedicalcare.com

Show more 3 emails
View Fresenius Medical Care Profile Verify Fresenius Medical Care Emails Export Fresenius Medical Care Prospects

Momentum Bioscience

momentumbio.co.uk

HQ: Reading, Reading, United Kingdom

HQ: Reading, Reading, United Kingdom

Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics, Medical Devices, Venture Capital

Business Type: Private
Employees: 11-50
Rounds: Series B
Last Investment Activity: Jul 4, 2024
Founded Date: 2005
Company Type: For Profit
Operating Status: Active

  • Matthew Crow

    Head of R&D

    m***w@momentumbio.co.uk

  • Sumi Thaker

    CEO

    s*****r@momentumbio.co.uk

  • General Inquiries

    info@momentumbio.co.uk

  • General Inquiries

    ninfo@momentumbio.co.uk

Show more 1 emails
View Momentum Bioscience Profile Verify Momentum Bioscience Emails Export Momentum Bioscience Prospects

Trendlines Group

trendlines.com

HQ: Misgav, HaZafon, Israel

HQ: Misgav, HaZafon, Israel

Specialized In: AgTech, Venture Capital, Finance & Banking, Biotechnology, Investment Banking, Medical Devices

Business Type: Public
Employees: 51-100
Rounds: Post-IPO Equity
Last Investment Activity: Sep 5, 2023
Founded Date: Jan 9, 1993
Number of Exits: 11
Company Type: For Profit
Stock Symbol: SGX:42T
Operating Status: Active
Investor Type: Micro VC

  • Todd Dollinger

    CEO

    t************r@trendlines.com

  • Eric Loh

    CEO, Trendlines Medical Singapore

    e**c@trendlines.com

  • General Inquiries

    info@trendlines.com

  • Admin Team

    admin@trendlines.com

Show more 1 emails
View Trendlines Group Profile Verify Trendlines Group Emails Export Trendlines Group Prospects

AbbVie

abbvie.com

HQ: North Chicago, Illinois, United States

HQ: North Chicago, Illinois, United States

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 22, 2024
Founded Date: 2013
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NYSE:ABBV
Operating Status: Active

  • Melanie Cohen

    m***********n@abbvie.com

  • Nancy Vangeys

    n***********s@abbvie.com

  • Customer Service

    customerservice@abbvie.com

  • Unclassified inbox

    talentacquisition@abbvie.com

Show more 311 emails
View AbbVie Profile Verify AbbVie Emails Export AbbVie Prospects

Medtronic

medtronic.com

HQ: Minneapolis, MN

HQ: Minneapolis, MN

Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Medical Devices, Hospitals & Clinics

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 27, 2024
Founded Date: 1949
Number of Exits: 28
Company Type: For Profit
Stock Symbol: NYSE:MDT
Operating Status: Active

  • Omar Ishrak

    CEO

    o**r@medtronic.com

  • Markowski

    Senior Manager

    m*******i@medtronic.com

  • Unclassified inbox

    michelle.r.claypool@medtronic.com

  • Unclassified inbox

    RS.MedtronicAcademy@medtronic.com

Show more 49 emails
View Medtronic Profile Verify Medtronic Emails Export Medtronic Prospects

Roche

roche.com

HQ: Basel, Basel-Stadt, Switzerland

HQ: Basel, Basel-Stadt, Switzerland

Specialized In: Biotechnology, Healthcare & Medical, Health Diagnostics, Pharmaceuticals

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Equity
Last Investment Activity: Mar 27, 2024
Founded Date: Jan 15, 1896
Number of Exits: 3
Company Type: For Profit
Stock Symbol: SWX:ROG
Operating Status: Active

  • Jason Hall

    Senior Business Analyst

    j********l@roche.com

  • Thomas Schinecker

    t***************r@roche.com

  • Unclassified inbox

    patientcare@roche.com

  • Unclassified inbox

    new_zealand.dia_communications@roche.com

Show more 24 emails
View Roche Profile Verify Roche Emails Export Roche Prospects

AstraZeneca

astrazeneca.com

HQ: Cambridge, Cambridgeshire, United Kingdom

HQ: Cambridge, Cambridgeshire, United Kingdom

Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 23, 2024
Founded Date: Apr 6, 1999
Number of Exits: 11
Company Type: For Profit
Stock Symbol: NSE:ASTRAZEN
Operating Status: Active

  • Marc Dunoyer

    Chief Strategy Officer

    m**********r@astrazeneca.com

  • Richard Gallo

    Oncology Contract Strategy Manager

    r***********o@astrazeneca.com

  • General Inquiries

    contact@astrazeneca.com

  • General Inquiries

    help@astrazeneca.com

Show more 24 emails
View AstraZeneca Profile Verify AstraZeneca Emails Export AstraZeneca Prospects

Bristol-Myers Squibb

bms.com

HQ: New York, NY

HQ: New York, NY

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 28, 2024
Founded Date: 1887
Number of Exits: 14
Company Type: For Profit
Stock Symbol: NYSE:BMY
Operating Status: Active
Investor Type: Venture Capital

  • John damonti

    Foundation President

    d******j@bms.com

  • Ron Behling

    r************g@bms.com

  • Unclassified inbox

    drugsafety@celgene.com

  • Unclassified inbox

    carmen.m.lopez@bms.com

Show more 22 emails
View Bristol-Myers Squibb Profile Verify Bristol-Myers Squibb Emails Export Bristol-Myers Squibb Prospects

Amgen

amgen.com

HQ: Thousand Oaks, California, United States

HQ: Thousand Oaks, California, United States

Specialized In: Biotechnology, Healthcare & Medical, Manufacturing & Industrial, Pharmaceuticals

Business Type: Public
Employees: 10001+
Rounds: Post-IPO Debt
Last Investment Activity: Mar 21, 2024
Founded Date: 1980
Number of Exits: 8
Company Type: For Profit
Stock Symbol: NASDAQ:AMGN
Operating Status: Active

  • Esteban Santos

    Executive Vice President, Operations

    e******s@amgen.com

  • Bob Bradway

    Chief Executive Officer

    b******y@amgen.com

  • Unclassified inbox

    HCCIME@amgen.com

  • Unclassified inbox

    medinfocanada@amgen.com

Show more 17 emails
View Amgen Profile Verify Amgen Emails Export Amgen Prospects

Moderna

modernatx.com

HQ: Cambridge, MA

HQ: Cambridge, MA

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 15, 2024
Founded Date: 2010
Number of Exits: 3
Company Type: For Profit
Stock Symbol: NASDAQ:MRNA
Operating Status: Active
Investor Type: Investment Bank

  • Huijuan Li

    Head, Analytical Development

    h********i@modernatx.com

  • Kerry Salandria

    Associate Director, Analytical Operations

    k*************a@modernatx.com

  • Unclassified inbox

    WeCare@modernatx.com

  • Unclassified inbox

    Grace.Chen@modernatx.com

Show more 17 emails
View Moderna Profile Verify Moderna Emails Export Moderna Prospects

Vertex Pharmaceuticals

vrtx.com

HQ: Boston, MA

HQ: Boston, MA

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Mar 1, 2024
Founded Date: 1989
Number of Exits: 2
Company Type: For Profit
Stock Symbol: NASDAQ:VRTX
Operating Status: Active

  • Thomas Carney

    Manager (GMP facility focus), Project Management Office, Global Capital Project Management

    t***********y@vrtx.com

  • Gillian

    Vice President, Strategic Operations, Regulatory Affairs and Quality

    g@vrtx.com

  • General Inquiries

    mediainfo@vrtx.com

  • Unclassified inbox

    cherif_benattia@vrtx.com

Show more 14 emails
View Vertex Pharmaceuticals Profile Verify Vertex Pharmaceuticals Emails Export Vertex Pharmaceuticals Prospects

Alexion Pharmaceuticals

alexion.com

HQ: Cheshire, Connecticut, United States

HQ: Cheshire, Connecticut, United States

Specialized In: Biotechnology, Healthcare & Medical, Hospitals & Clinics

Acquired by: AstraZeneca
Business Type: Public
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Apr 15, 2024
Founded Date: 1992
Number of Exits: 1
Company Type: For Profit
Stock Symbol: NASDAQ:ALXN
Operating Status: Active

  • Danielle Desrosiers

    Associate Director, Global Talent Acquisition Lead, Corporate Functions

    d*****************s@alexion.com

  • Don Owens

    Customer Success Manager

    d*n@alexion.com

  • Unclassified inbox

    AdverseEventReporting@alxn.com

  • Unclassified inbox

    dkeiser@alexion.com

Show more 12 emails
View Alexion Pharmaceuticals Profile Verify Alexion Pharmaceuticals Emails Export Alexion Pharmaceuticals Prospects

Jazz Pharmaceuticals

jazzpharma.com

HQ: Palo Alto, CA

HQ: Palo Alto, CA

Specialized In: Biotechnology, Healthcare & Medical, Pharmaceuticals

Business Type: Public
Employees: 501-1000
Rounds: Post-IPO Debt
Last Investment Activity: Feb 28, 2024
Founded Date: 2003
Company Type: For Profit
Stock Symbol: NASDAQ:JAZZ
Operating Status: Active

  • Bruce Cozadd

    Chief Executive Officer

    b**********d@jazzpharma.com

  • Charlotte Nortvedt

    c****************t@jazzpharma.com

  • General Inquiries

    investorinfo@jazzpharma.com

  • General Inquiries

    contact@jazzpharma.com

Show more 11 emails
View Jazz Pharmaceuticals Profile Verify Jazz Pharmaceuticals Emails Export Jazz Pharmaceuticals Prospects

Horizon Pharma

horizontherapeutics.com

HQ: Northbrook, Illinois, United States

HQ: Northbrook, Illinois, United States

Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Hospitals & Clinics

Business Type: Delisted
Employees: 1001-5000
Rounds: Post-IPO Equity
Last Investment Activity: Dec 12, 2022
Founded Date: 2005
Company Type: For Profit
Stock Symbol: NASDAQ:HZNP
Operating Status: Active

  • Shvetali Thatte

    s*************e@horizontherapeutics.com.If

    2**********0

  • Tina Ventura

    t**********a@horizontherapeutics.com

  • Customer Service

    customerservice@horizontherapeutics.com

  • Unclassified inbox

    jwhalen@horizonpharma.com

Show more 10 emails
View Horizon Pharma Profile Verify Horizon Pharma Emails Export Horizon Pharma Prospects

DSM

thedsmgroup.com

HQ: Heerlen, Limburg, undefinedNetherlands

HQ: Heerlen, Limburg, undefinedNetherlands

Specialized In: Biotechnology, Manufacturing & Industrial, Healthcare & Medical

Business Type: Public
Employees: 10001+
Rounds: Venture - Series Unknown
Last Investment Activity: Jul 30, 2024
Founded Date: 1902
Number of Exits: 1
Company Type: For Profit
Stock Symbol: OTCQX:RDSMY
Operating Status: Active

  • Dimitride Vreeze

    d**************e@dsm.com

  • Jos Groffils

    j**********s@dsm.com

  • Media Relations

    social.media@dsm.com

  • General Inquiries

    info@dsm.com

Show more 10 emails
View DSM Profile Verify DSM Emails Export DSM Prospects

ZOLL Medical Corporation

zoll.com

HQ: Chelmsford, Massachusetts, United States

HQ: Chelmsford, Massachusetts, United States

Specialized In: Biotechnology, Fitness, Healthcare & Medical, Technology & Software

Acquired by: Asahi Kasei
Business Type: Private
Employees: 1001-5000
Last Investment Activity: Mar 20, 2023
Founded Date: 1980
Number of Exits: 2
Company Type: For Profit
Operating Status: Active

  • Salman Sher

    Clinical Evidence Director

    s*********r@zoll.com

  • Hal Harmon

    Vice President of Global Operations

    h*****n@zoll.com

  • General Inquiries

    info@zoll.com

  • Unclassified inbox

    webmaster@zoll.com

Show more 9 emails
View ZOLL Medical Corporation Profile Verify ZOLL Medical Corporation Emails Export ZOLL Medical Corporation Prospects

KBI Biopharma

kbibiopharma.com

HQ: Durham, NC

HQ: Durham, NC

Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Manufacturing & Industrial

Business Type: Private
Employees: 1001-5000
Rounds: Venture - Series Unknown
Last Investment Activity: Apr 15, 2024
Founded Date: 1996
Number of Exits: 3
Company Type: For Profit
Operating Status: Active

  • Chad Cleveland

    Director - Data Integrity | Global Quality & Compliance

    c********d@kbibiopharma.com

  • Nicolas Fouque

    Director of Manufacturing Science and Technologies - Geneva

    n*****e@kbibiopharma.com

  • Unclassified inbox

    swakefield@kbibiopharma.com

  • General Inquiries

    contact@kbibiopharma.com

Show more 9 emails
View KBI Biopharma Profile Verify KBI Biopharma Emails Export KBI Biopharma Prospects